"Navigating the Modern News Zoo so you don't have to."
Sunday, June 15, 2025
Preventing stalling to improve CAR-T cells' efficacy against tumors
Chimeric antigen receptor (CAR)-T cells are a promising cancer therapy that are made from the patient's own T cells, which are reprogrammed to fight their cancer. One of the limitations of CAR-T cell therapy is the ability of these cells to survive long enough to target the entire tumor.
đ Full Story
Rethinking Food Sensitivities
- What Is So Bad About a Nuclear Iran? - Noah Rothman
- Unraveling the Mysteries of Black Holes and Entropy - Arya Chandran
- Retired vet buys lottery tickets to get tip money for pizza, ends up winning $1 million
- Crypto Airdrops: How and Where to Find Them
- Happiest Countries In The World 2025 - Luca Ventura
- The Innovative Approach to Track Small Space Debris - Arya Chandran
Jimmy Kimmelâs Audience Shocked at How Dumb He Actually Is
- As Russian losses in Ukraine hit 1 million, Putinâs war economy heads toward breaking point - MeighTimbol
- McDonald's confirms the return of fan-favorite item, release date and flavors
- Food Recalls This Week: Brown Eggs, Frozen Shrimp, and More Pulled From Shelves - Jenna Anderson
- ChatGPT Experiences Outage Amid OpenAI's Internal Turmoil - Michael Terry
- Evolutionary model for antibiotic resistance reveals dose timing critical to care
- <i>The Surrealist Collage</i> Show in Sync with Our Freaky Times - Brian T. Allen
